Skip to main navigation Skip to search Skip to main content

ReV as a Novel S. cerevisiae‑Derived Drug Carrier to Enhance Anticancer Therapy through Daunorubicin Delivery

Research output: Contribution to journal › Journal article › peer-review

Original languageKorean
JournalApplied Biochemistry and Biotechnology
StatePublished - 2025.04.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this